-
by Avery Swett | May 17, 2024 9:57 am | Medical Office Buildings, Other Services
Montecito Medical Real Estate, a leading acquirer of medical office properties nationwide, announced on May 16 its acquisition of a three-building portfolio in Northern Utah. The medical outpatient buildings (MOBs), which encompass a combined total of 48,527 square feet, are anchored and 100% occupied by Alpine Orthopaedic Specialists, a dominant...
Read More »
-
by Avery Swett | May 17, 2024 9:55 am | Laboratories, MRI & Dialysis, Private Equity
Versant Diagnostics has announced the acquisition of Associate Pathologists of Joliet, Ltd., expanding its nationwide network of pathology practices and increasing its presence in the Midwest. Led by its president, pathologist James Urban, M.D., Ph.D., Associate Pathologists of Joliet is a multi-specialty pathology practice based in Joliet,...
Read More »
-
by katehumphrey | May 16, 2024 3:25 pm | Biotechnology
On May 16 Johnson & Johnson (J&J) announced that it acquired Proteologix, Inc. for $850 million. Proteologix is privately held biotechnology company focused on bispecific antibodies for immune-mediated diseases. Proteologix’s portfolio includes PX128, a bispecific antibody targeting IL-13 plus TSLP, which is ready to enter phase 1...
Read More »
-
by katehumphrey | May 16, 2024 9:51 am | Laboratories, MRI & Dialysis
Genomenon has announced that it entered into an agreement to acquire Clinical Knowledgebase (CKB) from The Jackson Laboratory (JAX). CKB is the leading curated variant database used for interpreting complex cancer genomic profiles by some of the world’s premier oncology labs. Founded in 1929, JAX is an NCI-designated cancer...
Read More »
-
by katehumphrey | May 15, 2024 2:05 pm | Physician Medical Groups, Private Equity
Golden State Dermatology (DSD), a portfolio company of growth capital private equity firm, Sorenson Capital, announced that it acquired California Skin Surgery Center. California Skin Surgery Center is operated by Dr. Gregory M. Bricca, who works out of one location in Roseville, California. GSD is physician-owned and led and is...
Read More »
by Lisa Phillips | Jul 7, 2017 6:40 pm | Behavioral Health Care, Biotechnology, eHealth, Home Health & Hospice, Hospitals, Laboratories, MRI & Dialysis, Long-Term Care, Managed Care, Medical Devices, Other Services, Pharmaceuticals, Physician Medical Groups, Rehabilitation
Preliminary data for the month of June shows that investors are still bullish—or at least comfortable—betting on health care. Some 123 transactions were announced last month, an 11% decrease compared with May’s 138 transactions. Year over year, however, this early data is just 5% below the 130 deals announced in June 2016. For a little perspective, April 2017’s deal volume was just 104 transactions, which made the May numbers look very strong by comparison. June’s deal volume looks reassuringly healthy, as it is close to the year-ago total, and could be adjusted upward in the future as more deals come to light. The same trends we’ve noted in previous months are still playing out, too. Deal... Read More »
by Lisa Phillips | Jul 7, 2017 4:42 pm | Hospitals, Long-Term Care, Private Equity
Kindred Healthcare (NYSE: KND) has made no secret that it is getting out of the skilled nursing business. It took until June 30 for the deal announcement to come, and when it did, it was a bit of a surprise that a single buyer was taking over the entire business. Private equity firm BlueMountain Capital Management, LLC, through a joint venture it is leading called BM Eagle Holdings, agreed to acquire Kindred’s 89 skilled nursing facilities. BlueMountain, you may recall, acquired the financially failing Daughters of Charity hospital system in California in July 2015, following the collapse of Prime Healthcare Services’ $849 million bid in March 2015. A week after this deal with Kindred... Read More »
by Lisa Phillips | Jun 9, 2017 7:28 pm | Behavioral Health Care, CRO, eHealth, Home Health & Hospice, Hospitals, Laboratories, MRI & Dialysis, Long-Term Care, Managed Care, Medical Devices, Other Services, Pharmaceuticals, Physician Medical Groups, Rehabilitation
Preliminary data for the month of May shows an encouraging uptick in deal volume, with the services sectors making up 66% of the total. Some 134 transactions were announced last month, a 30% increase over April’s anemic 103 deal volume total. But monthly transaction totals in 2017 are not keeping pace with those in 2016. A year ago, 151 transactions were announced, 11% higher than in May 2017. There’s no question that the ongoing uncertainty surrounding the American Health Care Act hangs heavily on healthcare investors. The Senate Republicans have been at work behind closed doors to craft a different deal than the one sent to them by the House Republicans in mid-May. From the handful of... Read More »
by Lisa Phillips | May 3, 2017 8:26 pm | Behavioral Health Care, Biotechnology, eHealth, Home Health & Hospice, Hospitals, Laboratories, MRI & Dialysis, Long-Term Care, Managed Care, Medical Devices, Other Services, Pharmaceuticals, Physician Medical Groups, Rehabilitation
April usually doesn’t feel like February, at least, weather-wise. As far as healthcare mergers and acquisitions go, however, deal volume in April 2017 (103 deals) feels a lot like February’s deal volume (102). The chart below shows the clear winners and losers in April 2017. Deal volume was down 29% compared with the previous month (March, 145 deals), and slid 12% compared with the year before (April 2016, 141 deals). Healthcare services deal volume accounted for just 50% of April’s preliminary total. The services sectors typically account for higher percentages than the technology sectors (although that trend is reversed when it comes to dollar volume). The services side... Read More »
by Lisa Phillips | Mar 2, 2017 3:56 pm | Behavioral Health Care, Home Health & Hospice, Hospitals, Laboratories, MRI & Dialysis, Long-Term Care, Managed Care, Other Services, Physician Medical Groups, Private Equity, Rehabilitation
Every spring, we publish myraid statistics on the healthcare services deals announced the year before, in the form of The Health Care Services Acquisition Report. This year’s 23rd edition, which will available in late March, has this examination of what financial buyers targeted in 2016. Strategic buyers continued to dominate the health care services M&A market in 2016, as they have in the past. Their 683 deals made up 73% of the year’s deal volume. The $45.7 billion spent accounted for 63% of the combined total of $72 billion. A total of 259 deals, or 27% of the services deal volume in 2016, were carried out by financial buyers, such as private equity firms and real estate... Read More »
by Lisa Phillips | Jan 12, 2017 8:00 am | Biotechnology, eHealth, Home Health & Hospice, Hospitals, Long-Term Care
And so it begins. A new year, a new administration, and a foreboding that things can and will go wildly out of control in the healthcare industry, as the new administration dismantles the Affordable Care Act and doesn’t bother to replace it. Judging from the market’s behavior since the November 8 election, the notion that a Hillary Clinton victory was “baked in” to every healthcare deal doesn’t hold. Certainly some deals may have been put on hold following Donald Trump’s election, but 2016 ended with 1,536 deals, in our preliminary count. That’s 1% higher than 2015, which was the first year to break 1,500 transactions. Spending on deals in 2016, while not in record territory, was healthy.... Read More »